About: Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
Creator	Chatha, Kamaljit Drenos, Fotios Karteris, Emmanouil Kyrou, Ioannis Randeva, Harpal Robbins, Tim
source	Medline; PMC
abstract	BACKGROUND: In women of reproductive age, polycystic ovary syndrome (PCOS) constitutes the most frequent endocrine disorder. Women with PCOS are considered to typically belong to an age and sex group which is at lower risk for severe COVID-19. MAIN BODY: Emerging data link the risk of severe COVID-19 with certain factors such as hyper-inflammation, ethnicity predisposition, low vitamin D levels, and hyperandrogenism, all of which have known direct associations with PCOS. Moreover, in this common female patient population, there is markedly high prevalence of multiple cardio-metabolic conditions, such as type 2 diabetes, obesity, and hypertension, which may significantly increase the risk for adverse COVID-19-related outcomes. This strong overlap of risk factors for both worse PCOS cardio-metabolic manifestations and severe COVID-19 should be highlighted for the clinical practice, particularly since women with PCOS often receive fragmented care from multiple healthcare services. Comprehensively informing women with PCOS regarding the potential risks from COVID-19 and how this may affect their management is also essential. CONCLUSION: Despite the immense challenges posed by the COVID-19 outbreak to the healthcare systems in affected countries, attention should be directed to maintain a high standard of care for complex patients such as many women with PCOS and provide relevant practical recommendations for optimal management in the setting of this fast moving pandemic.
has issue date	2020-07-15(xsd:dateTime)
bibo:doi	10.1186/s12916-020-01697-5
bibo:pmid	32664957
has license	cc-by
sha1sum (hex)	478e3305a1781a8f42b3b73886c9e4986494c92a
schema:url	https://doi.org/10.1186/s12916-020-01697-5
resource representing a document's title	Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
has PubMed Central identifier	PMC7360476
has PubMed identifier	32664957
schema:publication	BMC Med
resource representing a document's body	covid:478e3305a1781a8f42b3b73886c9e4986494c92a#body_text
is schema:about of	named entity 'multiple' named entity 'COVID-19' named entity 'sex' named entity 'risk' named entity 'severe' named entity 'healthcare systems' named entity 'PCOS' named entity 'fragmented' named entity 'body' named entity 'female' named entity 'MANAGEMENT' named entity 'INFORMING' named entity 'FREQUENT' named entity 'HEALTHCARE SYSTEMS' named entity 'PREDISPOSITION' named entity 'strong' named entity 'severe' named entity 'receive' named entity 'severe' named entity 'complex' named entity 'Conclusion' named entity 'Women' named entity 'data link' named entity 'PCOS' named entity 'care' named entity 'patient' named entity 'COVID-19' named entity 'reproductive age' named entity 'risk factors' named entity 'metabolic conditions' named entity 'PCOS' named entity 'standard of care' named entity 'PCOS' named entity 'PCOS' named entity 'endocrine disorder' named entity 'COVID-19' named entity 'PCOS' named entity 'Polycystic ovary syndrome' named entity 'ACE inhibitors' named entity 'obesity' named entity 'COVID-19' named entity 'plasma' named entity 'macrophage' named entity 'proinflammatory cytokines' named entity 'PCOS' named entity 'PCOS' named entity 'sulphate' named entity 'comorbidities' named entity 'vitamin D levels' named entity 'kidneys' named entity 'ill health' named entity 'PCOS' named entity 'Spain' named entity 'NAFLD' named entity 'receptor' named entity 'polycystic ovary syndrome' named entity 'Continuous positive airway pressure' named entity 'COVID' named entity 'Minority Ethnic' named entity 'hypertension' named entity 'glucose' named entity 'gestational diabetes' named entity 'hirsutism' named entity 'clinical practice' named entity 'metabolic' named entity 'coronavirus' named entity 'COVID-19' named entity 'older age' named entity 'OSA' named entity 'SARS-CoV-2' named entity 'PCOS' named entity 'CPAP' named entity 'PCOS' named entity 'impaired glucose tolerance' named entity 'healthcare workers' named entity 'OSA'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software